Mbx Biosciences, Inc. · NASDAQ:MBX
Orbimed Advisors LLC reported a 9.00% stake in Mbx Biosciences, Inc. (Schedule 13D/A)
Event Sep 26, 2025 · Filed Sep 30, 2025
Orbimed Advisors LLC reported a 9.00% stake in Mbx Biosciences, Inc., 4,002,887 shares, with active intent on Sep 26, 2025. Filed Sep 30, 2025 (Schedule 13D/A).
- Stake
- 9.00%
- Shares
- 4,002,887
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 9.00% | 4,002,887 |
| ORBIMED CAPITAL GP VII LLC | 7.30% | 3,255,000 |
| OrbiMed Genesis GP LLC | 1.70% | 747,887 |
Source
Related
- Mbx Biosciences, Inc.
- Orbimed Advisors LLC
- Mbx Biosciences, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Feb 11, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026
- Form 4 · Hoerter Steven L. · Aug 4, 2026